|
|
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseWithdrawn |
First Approval Ctry. / Loc.US |
First Approval Date02 Apr 1974 |
|
|
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
Phase I Study of Alferon N Injection in Persons With Asymptomatic Human Immunodeficiency Virus (HIV) Infection
To determine the safety and tolerance of subcutaneous injections of natural interferon alpha (IFN) in asymptomatic HIV-positive persons and record its effects on the HIV virus in these individuals.
100 Clinical Results associated with The Purdue Frederick Co., Inc.
0 Patents (Medical) associated with The Purdue Frederick Co., Inc.
100 Deals associated with The Purdue Frederick Co., Inc.
100 Translational Medicine associated with The Purdue Frederick Co., Inc.